Back to search

Article

Splicing factor SRSF1 acts as a novel molecular brake for CD4 T cell activation and controls key molecular pathways in SLE

2023-04-27

Abstract excerpt

T cells from systemic lupus erythematosus (SLE) patients exhibit a hyperactive phenotype with defects in homeostasis, signaling and cytokine production. We previously uncovered new roles for serine arginine-rich splicing factor 1 (SRSF1) in the control of genes involved in signaling and cytokine production in T cells. SRSF1 expression is decreased in T cells from patients with SLE and low SRSF1 levels are associat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05e7699a-2ecb-516e-bc94-01fee1cbfca2
DOI
10.22541/au.168257725.57637198/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Splicing factor SRSF1 acts as a novel molecular brake for CD4 T cell activation and controls key molecular pathways in SLEDOI 10.22541/au.168257725.57637198/v1
Select a neighboring publication to make it the new centre.